These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2530799

  • 21. Platelet 3H-imipramine and 3H-paroxetine binding during treatment with psychoactive drugs.
    Mellerup ET, Dam H, Lauritzen L, Plenge P.
    Biol Psychiatry; 1991 Nov 15; 30(10):1056-8. PubMed ID: 1836743
    [No Abstract] [Full Text] [Related]

  • 22. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL, Clissold SP.
    Drugs; 1991 Feb 15; 41(2):225-53. PubMed ID: 1709852
    [Abstract] [Full Text] [Related]

  • 23. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
    Laruelle M, Vanisberg MA, Maloteaux JM.
    Biol Psychiatry; 1988 Jul 15; 24(3):299-309. PubMed ID: 2969755
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of the selective serotonin reuptake inhibitors.
    DeVane CL.
    J Clin Psychiatry; 1992 Feb 15; 53 Suppl():13-20. PubMed ID: 1531816
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection.
    Brett MA, Dierdorf HD, Zussman BD, Coates PE.
    J Chromatogr; 1987 Aug 07; 419():438-44. PubMed ID: 2959675
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The relationship between paroxetine and the sparteine oxidation polymorphism.
    Sindrup SH, Brøsen K, Gram LF, Hallas J, Skjelbo E, Allen A, Allen GD, Cooper SM, Mellows G, Tasker TC.
    Clin Pharmacol Ther; 1992 Mar 07; 51(3):278-87. PubMed ID: 1531950
    [Abstract] [Full Text] [Related]

  • 31. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study.
    Sindrup SH, Grodum E, Gram LF, Beck-Nielsen H.
    Ther Drug Monit; 1991 Sep 07; 13(5):408-14. PubMed ID: 1835549
    [Abstract] [Full Text] [Related]

  • 32. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI).
    J Clin Psychiatry; 1992 Feb 07; 53 Suppl():1-68. PubMed ID: 1531815
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Evaluation of 3H-paroxetine as a radiopharmaceutical for lung function].
    Hashimoto K, Goromaru T.
    Kaku Igaku; 1989 Jul 07; 26(7):879-85. PubMed ID: 2530375
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E, Pelicier Y, Archambault JC, Chabannes JP, Clerc G, Desvilles M, Guibert M, Pagot R, Poisat JL, Thobie Y.
    Acta Psychiatr Scand Suppl; 1989 Jul 07; 350():132-4. PubMed ID: 2530766
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunological evaluation of paroxetine.
    Henderson DC, Edwards RG, Weston BJ, Dewdney JM.
    Acta Psychiatr Scand Suppl; 1989 Jul 07; 350():40. PubMed ID: 2530784
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.